期刊文献+

p53基因治疗在恶性淋巴瘤治疗中的应用

Application of p53 gene therapy for malignant lymphoma
原文传递
导出
摘要 多数恶性淋巴瘤患者有突变的p53基因过表达,并且实验表明p53基因与恶性淋巴瘤的发生发展有密切关系。因此,以重组腺病毒为载体将正常p53基因导人肿瘤细胞中并使其稳定表达将会对恶性淋巴瘤起到治疗作用。这已经在基础研究中得到了证实。 In majority of malignant lymphoma patients the overexpression of mutant p53 gene can be found, and experiments show that p53 gene and the genesis currence and development of malignant lymphoma are closely related. Thus, normal p53 gene carried by recombinant adenovirus vector into tumor cells and its stable expression will play a theraputic role in the treatment of malignant lymphoma. This has been confirmed by the basic research.
出处 《国际肿瘤学杂志》 CAS 2008年第7期547-549,共3页 Journal of International Oncology
基金 国家自然科学基金资助项目(30471974)
关键词 基因法 淋巴瘤 基因 p53 Gene therapy Lymphoma Genes, p53
  • 相关文献

参考文献11

  • 1Xu H, El-Gewely MR. Differentally expressed downstream genes in cells with normal or mutated p53. Oncol Res, 2003, 13 (6-10) :429- 436.
  • 2Skunca Z, Gveric'-Krecak V, Dominis M, et al . Presence of bcl-2 and p53 proteins in patients with non-Hodgkln' s lymphoma at Zadar General Hospital. Acta Med Croatica, 2004, 58 (3) : 183-186.
  • 3Hussein MR, Al-Sabae TM, Georgis MN. Analysis of Bcl-2 and p53 protein expression in non-Hodgkin' s lymphoma. Ann Oncol, 2004, 15(12) :1849-1850.
  • 4Chang CC, Kampalath B, Schuhz C, et al . Expression of p53, c-Myc, or Bel-6 suggests a poor prognosis in primary central nervous system diffuse large B-cell lymphoma among immunocompetent individuals. Arch Pathol Lab Med, 2003, 127(2) :208-112.
  • 5Chabay P, De Matteo E, Preciado MV. Immunohistochemical expression of p53, bcl-2, and p21wafl in 48 Argentinean children with non-Hodgkin lymphoma. Appl Immunohistochem Mol Morphol, 2006, 14(1) :12-17.
  • 6Kohn OB, Sadelain M, Glorioso JC. Occourrence of leukaemia following gene therapy of X-linked SCID. Nat Rev Cancer, 2003, 3 (7) : 477-488.
  • 7Atencio IA, Grace M, Bordens R, et al . Biological activities of a recombinant adenovirus p53 ( SCH 58500 ) administered by hepatic arterial infusion in a Phase 1 colorectal cancer trial. Cancer Gene Ther, 2005, 13(2) :169-181.
  • 8Swisher SG, Roth JA, Komaki R, et al. Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 ( INGN 201 ) and radiation therapy. Clin Cancer Res, 2003,9( 1 ) :93-101.
  • 9Buttgereit P, Welneck S, Ropke G, et al. Efficient gene transfer into lymphoma cells using adenoviral vectors combined with lipofection. Cancer Gene Ther, 2000, 7(8) :1145-1155.
  • 10Chen HW, Lee YP, Chung YF, et al. Inducing long-term survival with lasting anti-tumor immunity in treating B cell lymphoma by a combined dendritic cell-based and hydrodynamic plasmid-encoding IL- 12 gene therapy. Int Immunol, 2003,15 (3) :427-435.

二级参考文献8

  • 1Kanwar J, Berg R, Lehnert K, et al. Taking lessons from dendritic cells: multiple xenogeneic ligands for leukocyte integrins have the potential to stimulate anti-tumor immunity.Gene Ther,1999,6:1835-1844.
  • 2Maxwell PH, Dachs GU, Gleadle JM, et al. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci U S A,1997,94:8104-8109.
  • 3Townsend SE, Allison JP. Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells.Science,1993,259:638-370.
  • 4Boehm T, Folkman J, Browder T, et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.Nature,1997,390:404-407.
  • 5Ferrara N, Houck K, Jakeman L, et al. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev,1992,13:18-32.
  • 6Ratcliffe PJ, O′Rourke JF, Maxwell PH, et al. Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression. J Exp Biol,1998, 201( Pt 8):1153-1162.
  • 7罗军,彭芝兰,王和,程易凡,杨开选,谢兰,钱晓蕾,邹燕.应用组织微阵列和原位杂交检测卵巢上皮性肿瘤中HIF-1α mRNA的表达[J].中华肿瘤杂志,2003,25(2):168-170. 被引量:8
  • 8王海平,陈孝平,丁磊,何松清,Ali Muthanna,李东华,张万广.乙肝病毒x蛋白激活缺氧诱导因子-1通路促进血管内皮生长因子表达的研究[J].中华肿瘤杂志,2003,25(5):433-436. 被引量:12

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部